Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash capital increase
Announcement on behalf of the material subsidiary,
Bora Bora Pharmaceutical Laboratories Inc., for the Board
resolution on cash capital increase
Date of events
2022/04/11
To which item it meets
paragraph 11
Statement
1.Date of the resolution by the board of directors or decision by the
Company:2022/04/11
2.Number of shares issued:40,000,000 shares
3.Par value per share:NTD 10 per share
4.Total monetary value of the issuance:NTD 400,000,000
5.Issue price:NTD 10 per share
6.Number of shares subscribed for by employees:4,000,000 shares
7.Ratio of shares subscribed for by existing shareholders:@10%
of the new issued shares are reserved for employee's
subscription, the remaining 90% will be subscribed by the
original shareholder based on their original share
proportionally
8.Method for public sale and no.of shares:Not applicable
9.Handling method for fractional shares and shares unsubscripted
for by the deadline:Authorize the chairman to seek with specific
person for unsubscript shares
10.Rights and obligations of these newly issued shares:
Same as originally issued shares
11.Utilization of the funds from the current capital increase:
For operation needs
12.Reference date of cash capital increase and share subscription:
2022/04/27
13.Last date before book closure:2022/04/22
14.Book closure starting date:2022/04/23
15.Book closure ending date:2022/04/27
16.Payment period:
(1)For original shareholder and employee:2022/04/29-2022/05/08
(2)For specific person:2022/05/09
17.Date of the agreement with the banks to collect and deposit the proceeds:
Not applicable
18.Name of the institution designated to collect the proceeds:Not applicable
19.Name of the bank designated to deposit the proceeds:Not applicable
20.Any other matters that need to be specified:No
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bora Pharmaceuticals Co. Ltd. published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 16:00:31 UTC.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash capital increase